Skip to main content
An official website of the United States government

Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin

Major Program
Supportive Care and Symptom Management
Sponsor
Mayo Clinic
Status
Completed
NCT ID
NCT03122886
This randomized pilot trial studies how well fat emulsion works in preventing hypersensitivity reactions in patients with cancer receiving carboplatin or oxaliplatin. Giving lipids before chemotherapy may prevent some drug reactions from carboplatin or oxaliplatin.
Intervention
Fat Emulsion, Placebo
Condition
Advanced Malignant Neoplasm
Investigators
Aminah Jatoi, M.D.

See list of participating sites